4.62
+0(+0.00%)
Currency In USD
| Previous Close | 4.62 |
| Open | 4.67 |
| Day High | 4.68 |
| Day Low | 4.49 |
| 52-Week High | 15.1 |
| 52-Week Low | 1.82 |
| Volume | 595,837 |
| Average Volume | 1.22M |
| Market Cap | 251.04M |
| PE | -1.28 |
| EPS | -3.6 |
| Moving Average 50 Days | 6.31 |
| Moving Average 200 Days | 8.59 |
| Change | 0 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $154.88 as of April 19, 2025 at a share price of $4.62. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $65.81 as of April 19, 2025 at a share price of $4.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Announces Stock Repurchase Program
GlobeNewswire Inc.
Mar 31, 2025 12:00 PM GMT
GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company’s common stock on or before March 27, 2026. “
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
GlobeNewswire Inc.
Mar 20, 2025 8:30 PM GMT
GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that its Compensation C
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
GlobeNewswire Inc.
Mar 20, 2025 12:06 PM GMT
Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in CanadaLONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Gr
Data not available